Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fokas

Showing results (301-310 of 329) with videos related to

Pageof 33
Sort By:
JAMA Surgery|June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical TrialJulia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
Oncotarget|October 27, 2016
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effectEsther A Kleibeuker, Emmanouil Fokas, Philip D Allen, et al.
Cancer Medicine|March 25, 2018
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)Stephanie E Combs, Maximilian Niyazi, Sebastian Adeberg, et al.
International Journal of Cancer|July 17, 2015
CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)Panagiotis Balermpas, Franz Rödel, Claus Rödel, et al.
Frontiers in Medicine|March 4, 2022
Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA NephropathyMarios Papasotiriou, Maria Stangou, Dimitris Chlorogiannis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG)D Martin, T Schreckenbach, P Ziegler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in GermanyDavid Krug, Markus Hecht, Nadja Ebert, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Dynamic Reprogramming of Stromal Pdgfra-expressing cells during WNT-Mediated Transformation of the Intestinal EpitheliumO Pellon-Cardenas, P Rout, S Hassan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Pageof 33

Showing results (301-310 of 329) with videos related to

Sort By:
Pageof 33
JAMA Surgery|June 7, 2018
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical TrialJulia Kitz, Emmanouil Fokas, Tim Beissbarth, et al.
Oncotarget|October 27, 2016
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effectEsther A Kleibeuker, Emmanouil Fokas, Philip D Allen, et al.
Cancer Medicine|March 25, 2018
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)Stephanie E Combs, Maximilian Niyazi, Sebastian Adeberg, et al.
International Journal of Cancer|July 17, 2015
CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)Panagiotis Balermpas, Franz Rödel, Claus Rödel, et al.
Frontiers in Medicine|March 4, 2022
Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA NephropathyMarios Papasotiriou, Maria Stangou, Dimitris Chlorogiannis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG)D Martin, T Schreckenbach, P Ziegler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in GermanyDavid Krug, Markus Hecht, Nadja Ebert, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Dynamic Reprogramming of Stromal Pdgfra-expressing cells during WNT-Mediated Transformation of the Intestinal EpitheliumO Pellon-Cardenas, P Rout, S Hassan, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Pageof 33